109 related articles for article (PubMed ID: 29188501)
21. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
22. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
23. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
24. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.
Zhang JL; Wang HY; Yang Q; Lin SY; Luo GY; Zhang R; Xu GL
World J Gastroenterol; 2015 Apr; 21(14):4240-7. PubMed ID: 25892874
[TBL] [Abstract][Full Text] [Related]
25. MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy.
Wen J; Luo K; Liu H; Liu S; Lin G; Hu Y; Zhang X; Wang G; Chen Y; Chen Z; Li Y; Lin T; Xie X; Liu M; Wang H; Yang H; Fu J
Ann Surg; 2016 May; 263(5):942-8. PubMed ID: 26445467
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma.
Owaki T; Matsumoto M; Okumura H; Uchicado Y; Kita Y; Setoyama T; Sasaki K; Sakurai T; Omoto I; Shimada M; Sakamoto F; Yoshinaka H; Ishigami S; Ueno S; Natsugoe S
Am J Surg; 2012 Feb; 203(2):191-7. PubMed ID: 21679919
[TBL] [Abstract][Full Text] [Related]
27. Utility of
Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL
J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732
[TBL] [Abstract][Full Text] [Related]
28. Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
Liu SL; Xi M; Yang H; Yang YD; Wu YJ; Zhao L; Zhang P; Luo LL; Liu MZ
Ann Surg Oncol; 2016 Jan; 23(1):273-81. PubMed ID: 26215200
[TBL] [Abstract][Full Text] [Related]
29. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
30. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer.
Nakajima Y; Nagai K; Miyake S; Ohashi K; Kawano T; Iwai T
Jpn J Cancer Res; 2002 Mar; 93(3):305-12. PubMed ID: 11927013
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
33. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
34. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
[TBL] [Abstract][Full Text] [Related]
36. Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy.
Fujishima F; Taniyama Y; Nakamura Y; Okamoto H; Ozawa Y; Ito K; Ishida H; Konno-Kumagai T; Kasajima A; Taniuchi S; Watanabe M; Kamei T; Sasano H
Dis Esophagus; 2018 Jul; 31(7):. PubMed ID: 29346536
[TBL] [Abstract][Full Text] [Related]
37. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
[TBL] [Abstract][Full Text] [Related]
38. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
39. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
Ohira M; Kubo N; Masuda G; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):4897-901. PubMed ID: 26254385
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]